# Lucas de Breed

> Lucas de Breed is a seed investor at BrightEdge Fund (Cambridge) backing Medical and Therapeutics. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [BrightEdge Fund](https://shizune.co/investors/profile/brightedge-fund)
- Location: Cambridge, United States
- Total investments: 1
- Last investment: Oct 2023
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/lucasdebreed

Lucas de Breed is a Director of American Cancer Society's BrightEdge Fund.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Modifi Bio | Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics. The company's strategy for combating cancer centers around modifying tumor DNA in a way that renders cancer cells irreparable while preserving the integrity of healthy cells. This unique approach empowers researchers to disrupt traditional oncology drugdevelopment methods. | $4.3M | Seed | Oct 16, 2023 |  |

1 of 1 investments shown.

## Co-investors
- [Connecticut Innovations](https://shizune.co/investors/profile/connecticut-innovations) — VC Fund, 1 deal together
- [HighCape Partners](https://shizune.co/investors/profile/highcape-partners) — VC Fund, 1 deal together
- [Ironwood Capital](https://shizune.co/investors/profile/ironwood-capital) — VC Fund, 1 deal together
- [National Brain Tumor Society](https://shizune.co/investors/profile/national-brain-tumor-society) — VC Fund, 1 deal together
- [Pathway Bioventures](https://shizune.co/investors/profile/pathway-bioventures) — VC Fund, 1 deal together
- [Sontag Family Trust](https://shizune.co/investors/profile/sontag-family-trust) — VC Fund, 1 deal together

## About BrightEdge Fund

VC Fund · Atlanta, United States

BrightEdge is the American Cancer Society’s donor-funded, philanthropic impact fund. The fund is led by a board comprised of the Society’s leaders and a management team with expertise in investment and venture capital. BrightEdge operates under a charitable fund model that invests in for-profit companies developing novel cancer-focused therapiesand technologies. The fund relies on the expertise of the Society’s medical and science professionals to evaluate the mission value of its investments. The fund’s goal is to accelerate delivery of promising cancer-related solutions through capital investment, market awareness and a shared commitment to eradicate cancer.

1 contacts available at BrightEdge Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Lucas de Breed | Director | https://shizune.co/investors/profile/lucas-de-breed |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Lucas de Breed invest in?

Lucas de Breed invests primarily in Medical, Therapeutics and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Lucas de Breed last invest?

The most recent investment recorded for Lucas de Breed closed in Oct 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co